SuperworthInsulet EPS PODD
Diluted earnings per share by quarter and over the last twelve months, from 2010.
- Last 12 months, to Jun 30, 2026
- $5.35
- Latest quarter, Q2 FY26
- $1.37
- +328% on a year earlier
- Fiscal year 2025
- $3.50
- −39% on the year before
Insulet's earnings per share was $5.35 over the twelve months to Jun 30, 2026, up 64% on a year earlier.
In its latest quarter, Q2 FY26, it was $1.37, up 328% on the same quarter a year before.
Over the five fiscal years to FY2025 it grew 104% a year on average.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $3.50 | −39% |
| FY2024 | $5.76 | +113% |
| FY2023 | $2.70 | +4400% |
| FY2022 | $0.06 | −74% |
| FY2021 | $0.23 | +130% |
| FY2020 | $0.10 | −44% |
| FY2019 | $0.18 | +13% |
| FY2018 | $0.16 | n/a |
| FY2017 | −$0.46 | n/a |
| FY2016 | −$0.48 | n/a |
| FY2015 | −$1.31 | n/a |
| FY2014 | −$0.93 | n/a |
| FY2013 | −$0.83 | n/a |
| FY2012 | −$1.08 | n/a |
| FY2011 | −$0.98 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $1.37 | +328% | $5.35 | |
| Q1 FY26 | $1.30 | +160% | $4.30 | |
| Q4 FY25 | $1.44 | +6% | $3.50 | |
| Q3 FY25 | $1.24 | +15% | $3.42 | |
| Q2 FY25 | $0.32 | −88% | $3.26 | |
| Q1 FY25 | $0.50 | −32% | $5.53 | |
| Q4 FY24 | $1.36 | +11% | $5.76 | |
| Q3 FY24 | $1.08 | +46% | $5.63 | |
| Q2 FY24 | $2.59 | +564% | $5.29 | |
| Q1 FY24 | $0.73 | +115% | $3.09 | |
| Q4 FY23 | $1.23 | +413% | $2.70 | |
| Q3 FY23 | $0.74 | n/a | $1.71 |
Against its peers
Companies in Medical - Instruments & Supplies nearest Insulet's size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| PODDInsulet | $5.35 | +64% a year |
| GMEDGlobus Medical | $3.91 | +50% a year |
| ALGNAlign Technology | $5.75 | −3% a year |
| COOCooper Companies | $2.93 | +44% a year |
| PENPenumbra | $4.07 | +8% a year |
| SOLVSolventum | $8.18 | +277% a year |
| MSAMSA Safety | $8.04 | +15% a year |
| MMSIMerit Medical Systems | $2.42 | +23% a year |
| HAEHaemonetics | $2.04 | −38% a year |
| VNTVontier | $2.41 | −8% a year |
| BMIBadger Meter | $4.28 | −8% a year |
| Peer median | $3.99 |
Where Insulet ranks
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Insulet
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.